Susquehanna International Group, LLP Kiniksa Pharmaceuticals, Ltd. Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.63 - $21.74 $1.68 Million - $2.07 Million	95,330 Added 265.59%	131,223 $2.59 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $2.49 Million - $3.31 Million	-173,527 Reduced 82.86%	35,893 $629,000
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $2.67 Million - $3.95 Million	195,772 Added 1434.44%	209,420 $3.64 Million
Q2 2023 Aug 11, 2023	SELL	$10.44 - $16.48 $871,009 - $1.37 Million	-83,430 Reduced 85.94%	13,648 $192,000
Q1 2023 May 16, 2023	BUY	$10.7 - $15.79 $564,703 - $833,333	52,776 Added 119.13%	97,078 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $505,928 - $755,349	44,302 New	44,302 $663,000
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $806,058 - $1.07 Million	-86,673 Reduced 73.74%	30,868 $307,000
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $100,263 - $146,197	-9,650 Reduced 7.59%	117,541 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $366,507 - $522,248	32,178 Added 33.87%	127,191 $1.45 Million
Q2 2021 Aug 11, 2021	BUY	$13.22 - $19.09 $451,330 - $651,732	34,140 Added 56.08%	95,013 $1.32 Million
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $819,188 - $1.18 Million	49,112 Added 417.58%	60,873 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $66,955 - $95,682	-4,524 Reduced 27.78%	11,761 $208,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $247,694 - $415,756	16,285 New	16,285 $249,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.